CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A modular, multi-arm, multi-part, first time in patient study to evaluate the safety and tolerability of the dual MET kinase/OCT2 inhibitor, OMO-1, alone and in combination with anti-cancer treatments, in patients with locally advanced, unresectable or metastatic solid malignancies.
Author
Ann Meulemans
Elizabeth Ruth Plummer
+15Â more
ERIC ANGEVIN
Filip Yves Francine Leon De Vos
Glen Clack
Joachim G.J.V. Aerts
Marion Libouban
Martijn P. Lolkema
Martin Forster
Matthew Krebs
Nadina Tinsley
Prashanth Hari Dass
Rebecca Sophie Kristeleit
Sarah Patricia Blagden
Shankar Balaratnam
Tim Perera
Yvette Drew
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref